Transcept Pharmaceuticals, Inc.
Pharmaceutical ManufacturingUnited States11-50 Employees
A specialty pharmaceutical company acquired by Paratek Pharmaceuticals (Nasdaq:PRTK) on October 30, 2014..
Specialized Market Focus Transcept Pharmaceuticals operates as a niche player within the pharmaceutical manufacturing industry, offering specialized treatments. This presents an opportunity for tailored medical solutions and services that cater to the company's specific research and development needs.
Growth Potential With revenue estimates between 1 million and 10 million dollars and a relatively small team, Transcept shows potential for targeted product expansion and partnership opportunities to accelerate growth and market reach.
Technology Utilization The company's use of common web technologies like Google Analytics and OpenResty suggests a digital presence that can be leveraged for outreach, customer engagement, and data-driven marketing strategies to increase visibility.
Recent Acquired Status Having been acquired by Paratek Pharmaceuticals, Transcept may be positioned for resource sharing and integration into larger pharmaceutical networks, offering avenues for joint ventures and collaborative research.
Industry Positioning Compared to larger competitors such as Jazz Pharmaceuticals and Purdue Pharma, Transcept's niche focus offers an opportunity for personalized sales approaches and the development of specialized services to meet unique customer needs.
Transcept Pharmaceuticals, Inc. uses 5 technology products and services including Google Fonts API, jQuery, Google Analytics, and more. Explore Transcept Pharmaceuticals, Inc.'s tech stack below.
| Transcept Pharmaceuticals, Inc. Email Formats | Percentage |
| FLast@transcept.com | 44% |
| First@transcept.com | 6% |
| Last@transcept.com | 6% |
| FLast@transcept.com | 44% |
Pharmaceutical ManufacturingUnited States11-50 Employees
A specialty pharmaceutical company acquired by Paratek Pharmaceuticals (Nasdaq:PRTK) on October 30, 2014..
Transcept Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $1M$10M
Transcept Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $1M$10M